Abbott Laboratories Infinity™ implantable deep brain stimulation system for depressive disorder, treatment-resistant

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 16 May 2019: Trial registered, NCT03952962

The trials

NCT03952962: Tractography Guided Subcallosal Cingulate Deep Brain Stimulation for Treatment Resistant Depression

State
Under way
Phase
No phase
People
12 planned
Started
28 Oct 2022
Primary completion
Jul 2027
Arms
Randomized Discontinuation Period: OFF then ON DBS, Randomized Discontinuation Period: ON then OFF DBS
Results
None posted
  1. 16 May 2019: Trial registered
  2. 28 Oct 2022: Trial started

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Device.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.